Preclinical efficacy of the synergistic Ruxolitinib–Homoharringtonine combination in TP53-mutated myeloproliferative neoplasms progressing to sAML
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Rumeng Li, Qingmei Han, Tian Zeng, Jiansong Huang, Jian Huang
Institution: First Affiliated Hospital Zhejiang University
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417010048
Cites:
Cited by:
Related to: